These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 6255865)

  • 1. Effect of beta-lactamase and salt on mecillinam susceptibility of enterobacterial strains.
    Bongaerts GP; Bruggeman-Ogle KM
    Antimicrob Agents Chemother; 1980 Nov; 18(5):680-6. PubMed ID: 6255865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activity of mecillinam alone and in combination with other beta-lactam antibiotics.
    Fass RJ
    Antimicrob Agents Chemother; 1980 Dec; 18(6):906-12. PubMed ID: 6263179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In-vitro activity of the combinations of ampicillin with mecillinam or with beta-lactamase inhibitors against strains resistant to ampicillin.
    Verbist L
    J Antimicrob Chemother; 1985 Dec; 16(6):719-25. PubMed ID: 3879248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro activity of ampicillin alone and in combination with different concentrations of 6 beta-bromopenicillanic acid, clavulanic acid and mecillinam.
    Stobberingh EE; Houben AW; van Boven CP
    Scand J Infect Dis; 1987; 19(1):105-12. PubMed ID: 3031812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibiotic sensitivity of enteropathogenic Escherichia coli to mecillinam, trimethoprim-sulfamethoxazole and other antibiotics.
    Thorén A
    Acta Pathol Microbiol Scand B; 1980 Oct; 88(5):265-8. PubMed ID: 6258383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Inhibitory activity of ampicillin and mecillinam on Haemophilus influenzae].
    Dabernat H; Delmas C; Lareng MB
    Pathol Biol (Paris); 1984 May; 32(5):378-80. PubMed ID: 6330648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synergistic and bactericidal activities of mecillinam, amoxicillin and clavulanic acid combinations against extended-spectrum β-lactamase (ESBL)-producing Escherichia coli in 24-h time-kill experiments.
    Skarp KP; Shams A; Montelin H; Lagerbäck P; Tängdén T
    Int J Antimicrob Agents; 2019 Jan; 53(1):74-79. PubMed ID: 30236958
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative potency of mecillinam and other beta-lactam antibiotics against Escherichia coli strains producing different beta-lactamases.
    Sougakoff W; Jarlier V
    J Antimicrob Chemother; 2000 Sep; 46 Suppl 1():9-14; discussion 63-5. PubMed ID: 11051618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro activity of mecillinam and amoxicillin/clavulanic acid against strains of Escherichia coli producing TEM-1, Oxa-1 and chromosomal beta-lactamases.
    Marre R; Schulz E
    Arzneimittelforschung; 1988 Jul; 38(7):863-5. PubMed ID: 3061383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Results from a Prospective
    Fuchs F; Hamprecht A
    Antimicrob Agents Chemother; 2019 Apr; 63(4):. PubMed ID: 30917983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synergistic activity of mecillinam in combination with the beta-lactamase inhibitors clavulanic acid and sulbactam.
    Neu HC
    Antimicrob Agents Chemother; 1982 Sep; 22(3):518-9. PubMed ID: 6291454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of beta-lactamase and the outer-membrane structure in the resistance of Enterobacteriaceae to mecillinam.
    Bongaerts GP; Bruggeman-Ogle K
    Antonie Van Leeuwenhoek; 1980; 46(1):99. PubMed ID: 6249199
    [No Abstract]   [Full Text] [Related]  

  • 13. Activity of mecillinam against Escherichia coli resistant to third-generation cephalosporins.
    Wootton M; Walsh TR; Macfarlane L; Howe RA
    J Antimicrob Chemother; 2010 Jan; 65(1):79-81. PubMed ID: 19915068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative activity of mecillinam and ampicillin singly and in combination in the urinary bladder model and experimental mouse model.
    Anderson JD; Eftekhar F; Cleeland R; Kramer MJ; Beskid G
    J Antimicrob Chemother; 1981 Aug; 8(2):121-31. PubMed ID: 6268599
    [No Abstract]   [Full Text] [Related]  

  • 15. In vitro activity of mecillinam against anaerobic bacteria.
    Steinkraus GE; McCarthy LR
    Antimicrob Agents Chemother; 1980 Jun; 17(6):954-6. PubMed ID: 6250471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro activity of moxalactam and mecillinam, singly and in combination, against multi-drug-resistant Enterobacteriaceae and Pseudomonas species.
    Fass RJ
    Antimicrob Agents Chemother; 1982 Jan; 21(1):188-91. PubMed ID: 6282206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In-vitro susceptibility of beta-lactamase-producing Haemophilus influenzae to the combinations ampicillin with mecillinam and ampicillin and VD2085.
    Piot P; van Dyck E
    J Antimicrob Chemother; 1985 Dec; 16(6):808-9. PubMed ID: 3005221
    [No Abstract]   [Full Text] [Related]  

  • 18. [Comparison of antibacterial activity of mecillinam against recently isolated bacilli of 5 genera of Enterobacteriaceae from clinical materials with ampicillin, amoxicillin, cephalexin, nalidixic acid and pipemidic acid (author's transl)].
    Kosakai N; Oguri T
    Jpn J Antibiot; 1979 Aug; 32(8):812-8. PubMed ID: 226736
    [No Abstract]   [Full Text] [Related]  

  • 19. Mecillinam susceptibility as an indicator of beta-lactamase production in Staphylococcus aureus.
    Bruun B; Gahrn-Hansen B
    Clin Microbiol Infect; 2002 Feb; 8(2):122-4. PubMed ID: 11952728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mecillinam.
    Bakhtiar M; Selwyn S
    Lancet; 1978 Feb; 1(8059):337. PubMed ID: 75379
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.